Revenue growth was mixed at 3.7% in 2026Q2, but gross margin compressed to 24.4% from 26.6% a year earlier, and a $215.4M impairment drove operating margin to -39.3%.
Minerals Technologies Inc. (MTX) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 2.15B | 2.07B | 2.12B | 2.17B | 2.13B | 1.86B | 1.59B | 1.79B | 1.81B | 1.68B | 1.64B | 1.8B | 1.73B | 1.02B | 1.01B | 1.04B | 1B | 907.32M | 1.11B | 1.08B | 1.06B | 995.84M | 923.67M | 813.74M | 752.68M | 684.42M | 670.92M | 637.5M | 609.2M | 602.3M | 556M |
| Revenue Growth % | 4.06% | -2.17% | -2.37% | 2.09% | 14.38% | 16.52% | -10.95% | -0.92% | 7.87% | 2.3% | -8.88% | 4.21% | 69.42% | 1.25% | -3.75% | 4.24% | 10.47% | -18.42% | 3.2% | 1.74% | 6.37% | 7.81% | 13.51% | 8.11% | 9.97% | 2.01% | 5.24% | 4.65% | 1.15% | 8.33% | 6.01% |
| Cost of Goods Sold | 1.62B | 1.57B | 1.58B | 1.68B | 1.67B | 1.42B | 1.2B | 1.36B | 1.35B | 1.22B | 1.19B | 1.33B | 1.29B | 784.54M | 786.25M | 832.66M | 793.16M | 751.5M | 891.74M | 845.14M | 798.73M | 780.55M | 709.03M | 615.75M | 567.99M | 502.52M | 416.72M | 379.9M | 363.4M | 371.7M | 350.1M |
| COGS % of Revenue | - | 75.56% | 74.72% | 77.22% | 78.72% | 76.54% | 75.16% | 75.91% | 74.96% | 72.6% | 72.39% | 74.23% | 75.04% | 77.05% | 78.19% | 79.69% | 79.13% | 82.83% | 80.18% | 78.42% | 75.4% | 78.38% | 76.76% | 75.67% | 75.46% | 73.42% | 62.11% | 59.59% | 59.65% | 61.71% | 62.97% |
| Gross Profit | 526.4M | 506.6M | 535.6M | 494.4M | 452.3M | 435.9M | 396.1M | 431.5M | 452.6M | 459.2M | 452.2M | 463.2M | 430.6M | 233.65M | 219.37M | 212.2M | 209.19M | 155.82M | 220.47M | 232.59M | 224.81M | 210.2M | 214.63M | 197.99M | 184.69M | 181.89M | 254.2M | 257.6M | 245.8M | 230.6M | 205.9M |
| Gross Margin % | 24.52% | 24.44% | 25.28% | 22.78% | 21.28% | 23.46% | 24.84% | 24.09% | 25.04% | 27.4% | 27.61% | 25.77% | 24.96% | 22.95% | 21.81% | 20.31% | 20.87% | 17.17% | 19.82% | 21.58% | 21.22% | 21.11% | 23.24% | 24.33% | 24.54% | 26.58% | 37.89% | 40.41% | 40.35% | 38.29% | 37.03% |
| Gross Profit Growth % | - | -5.41% | 8.33% | 9.31% | 3.76% | 10.05% | -8.2% | -4.66% | -1.44% | 1.55% | -2.37% | 7.57% | 84.3% | 6.51% | 3.38% | 1.44% | 34.25% | -29.33% | -5.21% | 3.46% | 6.95% | -2.07% | 8.4% | 7.2% | 1.54% | -28.44% | -1.32% | 4.8% | 6.59% | 12% | 8.83% |
| Operating Expenses | 533.9M | 219.5M | 250.1M | 214.5M | 199.8M | 195.1M | 187.1M | 198.7M | 192.5M | 196.4M | 195M | 205.9M | 201.8M | 109.28M | 109.33M | 111.29M | 110.05M | 111.02M | 124.91M | 241.08M | 132.39M | 129.43M | 123.42M | 117.47M | 103.82M | 97.93M | 164.49M | 160.2M | 153.3M | 150.4M | 138.4M |
| OpEx % of Revenue | - | 10.59% | 11.81% | 9.89% | 9.4% | 10.5% | 11.73% | 11.09% | 10.65% | 11.72% | 11.9% | 11.45% | 11.7% | 10.73% | 10.87% | 10.65% | 10.98% | 12.24% | 11.23% | 22.37% | 12.5% | 13% | 13.36% | 14.44% | 13.79% | 14.31% | 24.52% | 25.13% | 25.16% | 24.97% | 24.89% |
| Selling, General & Admin | 220.2M | 196.6M | 227.1M | 193.3M | 179.4M | 175.6M | 167.2M | 178.4M | 169.8M | 172.7M | 171.2M | 182.3M | 177.4M | 89.23M | 89.16M | 91.96M | 90.47M | 91.08M | 101.86M | 104.65M | 106.39M | 100.36M | 94.42M | 89.12M | 80.37M | 74.42M | 77.37M | 76.5M | 79.2M | 77.1M | 72.5M |
| SG&A % of Revenue | - | 9.49% | 10.72% | 8.91% | 8.44% | 9.45% | 10.48% | 9.96% | 9.39% | 10.31% | 10.45% | 10.14% | 10.28% | 8.76% | 8.87% | 8.8% | 9.03% | 10.04% | 9.16% | 9.71% | 10.04% | 10.08% | 10.22% | 10.95% | 10.68% | 10.87% | 11.53% | 12% | 13% | 12.8% | 13.04% |
| Research & Development | 23.4M | 22.9M | 23M | 21.2M | 20.4M | 19.5M | 19.9M | 20.3M | 22.7M | 23.7M | 23.8M | 23.6M | 24.4M | 20.05M | 20.17M | 19.33M | 19.58M | 19.94M | 23.05M | 26.35M | 30.02M | 29.06M | 29M | 25.15M | 22.7M | 23.51M | 26.33M | 25M | 21M | 20.4M | 19.7M |
| R&D % of Revenue | - | 1.1% | 1.09% | 0.98% | 0.96% | 1.05% | 1.25% | 1.13% | 1.26% | 1.41% | 1.45% | 1.31% | 1.41% | 1.97% | 2.01% | 1.85% | 1.95% | 2.2% | 2.07% | 2.44% | 2.83% | 2.92% | 3.14% | 3.09% | 3.02% | 3.43% | 3.92% | 3.92% | 3.45% | 3.39% | 3.54% |
| Other Operating Expenses | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 110.09M | -4.02M | 0 | 0 | 3.2M | 750K | 0 | 60.8M | 58.7M | 53.1M | 52.9M | 46.2M |
| Operating Income | -7.5M | 287.1M | 285.5M | 279.9M | 252.5M | 240.8M | 209M | 232.8M | 260.1M | 262.8M | 257.2M | 257.3M | 228.8M | 124.36M | 110.04M | 100.91M | 99.14M | 44.8M | 95.56M | -8.5M | 92.43M | 80.77M | 91.22M | 77.2M | 80.87M | 80.56M | 89.71M | 97.4M | 92.5M | 80.2M | 67.5M |
| Operating Margin % | -0.35% | 13.85% | 13.48% | 12.9% | 11.88% | 12.96% | 13.11% | 13% | 14.39% | 15.68% | 15.7% | 14.31% | 13.26% | 12.21% | 10.94% | 9.66% | 9.89% | 4.94% | 8.59% | -0.79% | 8.73% | 8.11% | 9.88% | 9.49% | 10.74% | 11.77% | 13.37% | 15.28% | 15.18% | 13.32% | 12.14% |
| Operating Income Growth % | - | 0.56% | 2% | 10.85% | 4.86% | 15.22% | -10.22% | -10.5% | -1.03% | 2.18% | -0.04% | 12.46% | 83.98% | 13.01% | 9.05% | 1.78% | 121.29% | -53.12% | 1224.43% | -109.2% | 14.43% | -11.45% | 18.15% | -4.54% | 0.39% | -10.2% | -7.9% | 5.3% | 15.34% | 18.81% | 14.99% |
| EBITDA | 90.5M | 392M | 393.1M | 387.2M | 355.8M | 343M | 310.8M | 339.4M | 350.6M | 349.7M | 351.6M | 358.4M | 314.9M | 172.35M | 161.95M | 159.73M | 163.92M | 117.9M | 176.41M | 76.87M | 176.35M | 154.03M | 161.69M | 143.54M | 149.83M | 147.07M | 150.5M | 156.1M | 145.6M | 133.1M | 113.7M |
| EBITDA Margin % | 4.21% | 18.91% | 18.56% | 17.84% | 16.74% | 18.46% | 19.49% | 18.95% | 19.4% | 20.87% | 21.47% | 19.94% | 18.26% | 16.93% | 16.1% | 15.29% | 16.35% | 12.99% | 15.86% | 7.13% | 16.65% | 15.47% | 17.5% | 17.64% | 19.91% | 21.49% | 22.43% | 24.49% | 23.9% | 22.1% | 20.45% |
| EBITDA Growth % | -77.37% | -0.28% | 1.52% | 8.83% | 3.73% | 10.36% | -8.43% | -3.19% | 0.26% | -0.54% | -1.9% | 13.81% | 82.71% | 6.42% | 1.39% | -2.56% | 39.03% | -33.17% | 129.5% | -56.41% | 14.5% | -4.74% | 12.64% | -4.2% | 1.88% | -2.28% | -3.59% | 7.21% | 9.39% | 17.06% | 14.85% |
| D&A (Non-Cash Add-back) | 98M | 104.9M | 107.6M | 107.3M | 103.3M | 102.2M | 101.8M | 106.6M | 90.5M | 86.9M | 94.4M | 101.1M | 86.1M | 47.99M | 51.91M | 58.82M | 64.78M | 73.1M | 80.85M | 85.36M | 83.93M | 73.25M | 70.47M | 66.34M | 68.96M | 66.52M | 60.8M | 58.7M | 53.1M | 52.9M | 46.2M |
| EBIT | -21.2M | 50.7M | 285.8M | 170.8M | 204M | 242.9M | 178.1M | 202.7M | 250M | 234.3M | 224.7M | 193.5M | 164.8M | 126.97M | 110.27M | 100.99M | 102.19M | -19.65M | 87.45M | -112.89M | 88.36M | 83.24M | 88.72M | 80.53M | 80.87M | 83.96M | 84.81M | 97.4M | 92.4M | 80.2M | 67.5M |
| Net Interest Income | -52.1M | -54.5M | -56.4M | -59.2M | -43.9M | -37.2M | -38.2M | -43.2M | -45.9M | -43.4M | -54.4M | -60.9M | -41.8M | -247K | -53K | 653K | -571K | -3.49M | -276K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.8M | 5.3M | 5.8M | 3.9M | 3.4M | 3.4M | 1.9M | 2.2M | 0 | 0 | 0 | 0 | 0 | 3.02M | 3.17M | 3.91M | 2.77M | 0 | 4.91M | 3.08M | 1.76M | 1.38M | 1.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 54.9M | 59.8M | 62.2M | 63.1M | 47.3M | 40.6M | 40.1M | 45.4M | 45.9M | 43.4M | 54.4M | 60.9M | 41.8M | 3.26M | 3.22M | 3.25M | 3.34M | 3.49M | 5.18M | 8.7M | 7.75M | 5.85M | 4.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -68.4M | -296.2M | -55.2M | -167.9M | -94.1M | -35.7M | -68.8M | -73.6M | -52.5M | -70.4M | -84.8M | -122.9M | -104.6M | -651K | -3M | -3.17M | -293K | -67.94M | -13.3M | -3M | -5.87M | -3.38M | -6.65M | -4.86M | -6.9M | -9.62M | -6.86M | -6.4M | -7.8M | -6.8M | -4.9M |
| Pretax Income | -75.9M | -9.1M | 230.3M | 112M | 158.4M | 205.1M | 140.2M | 159.2M | 207.6M | 192.4M | 172.4M | 134.4M | 124.2M | 123.71M | 107.05M | 97.74M | 98.85M | -23.14M | 82.27M | -11.5M | 86.56M | 77.39M | 84.57M | 72.34M | 73.97M | 70.94M | 77.94M | 91M | 84.6M | 73.4M | 62.6M |
| Pretax Margin % | -3.53% | -0.44% | 10.87% | 5.16% | 7.45% | 11.04% | 8.79% | 8.89% | 11.48% | 11.48% | 10.53% | 7.48% | 7.2% | 12.15% | 10.64% | 9.35% | 9.86% | -2.55% | 7.4% | -1.07% | 8.17% | 7.77% | 9.16% | 8.89% | 9.83% | 10.37% | 11.62% | 14.27% | 13.89% | 12.19% | 11.26% |
| Income Tax | -13.2M | 4.9M | 59.4M | 23.7M | 32.1M | 36.6M | 24.4M | 22.8M | 34.4M | -6.6M | 35.3M | 22.8M | 30.8M | 34.52M | 30.78M | 27.49M | 28.96M | -5.39M | 24.08M | 11.27M | 26.99M | 22.98M | 24.3M | 4.12M | 20.22M | 21.15M | 23.73M | 28.9M | 27.4M | 23.1M | 19.5M |
| Effective Tax Rate % | 17.39% | -53.85% | 25.79% | 21.16% | 20.27% | 17.84% | 17.4% | 14.32% | 16.57% | -3.43% | 20.48% | 16.96% | 24.8% | 27.9% | 28.75% | 28.12% | 29.3% | 23.28% | 29.27% | -97.97% | 31.18% | 29.7% | 28.73% | 5.69% | 27.33% | 29.81% | 30.45% | 31.76% | 32.39% | 31.47% | 31.15% |
| Net Income | -67.3M | -18.4M | 167.1M | 84.1M | 122.2M | 164.4M | 112.4M | 132.7M | 169M | 195.1M | 133.4M | 107.9M | 92.4M | 80.33M | 74.15M | 67.52M | 66.87M | -23.8M | 65.29M | -63.51M | 49.95M | 53.26M | 58.56M | 70.09M | 53.75M | 49.79M | 54.21M | 62.1M | 57.2M | 50.3M | 43.1M |
| Net Margin % | -3.13% | -0.89% | 7.89% | 3.88% | 5.75% | 8.85% | 7.05% | 7.41% | 9.35% | 11.64% | 8.14% | 6% | 5.36% | 7.89% | 7.37% | 6.46% | 6.67% | -2.62% | 5.87% | -5.89% | 4.72% | 5.35% | 6.34% | 8.61% | 7.14% | 7.28% | 8.08% | 9.74% | 9.39% | 8.35% | 7.75% |
| Net Income Growth % | -3304.76% | -111.01% | 98.69% | -31.18% | -25.67% | 46.26% | -15.3% | -21.48% | -13.38% | 46.25% | 23.63% | 16.77% | 15.03% | 8.34% | 9.81% | 0.97% | 381.01% | -136.45% | 202.79% | -227.15% | -6.22% | -9.05% | -16.44% | 30.39% | 7.95% | -8.14% | -12.71% | 8.57% | 13.72% | 16.71% | 9.11% |
| Net Income (Continuing) | -62.7M | -14M | 170.9M | 88.3M | 126.3M | 168.5M | 115.8M | 136.4M | 173.2M | 199M | 137.1M | 111.6M | 93.4M | 89.19M | 76.27M | 70.25M | 69.89M | -17.75M | 58.19M | -22.77M | 59.57M | 54.41M | 60.27M | 51.65M | 53.75M | 49.79M | 54.21M | 62.1M | 57.2M | 50.3M | 43.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.1M | 0 | 0 | 0 | 0 | 0 | 10.28M | 0 | 0 | 589K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 36.3M | 36.2M | 34.7M | 33.7M | 40.2M | 37.9M | 31.9M | 31.8M | 27.4M | 24.4M | 27.2M | 25.9M | 22.31M | 23.31M | 26.41M | 27.17M | 23.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.6M |
| EPS (Diluted) | -2.16 | -0.59 | 5.17 | 2.58 | 3.73 | 4.86 | 3.29 | 3.78 | 4.75 | 5.48 | 3.79 | 3.08 | 2.65 | 2.30 | 2.09 | 1.86 | 1.79 | -0.64 | 1.72 | -1.65 | 1.26 | 1.20 | 1.41 | 1.18 | 1.31 | 1.24 | 1.29 | 1.40 | 1.25 | 1.09 | 0.93 |
| EPS Growth % | -3733.33% | -111.41% | 100.39% | -30.83% | -23.25% | 47.72% | -12.96% | -20.42% | -13.32% | 44.59% | 23.05% | 16.23% | 15.22% | 10.05% | 12.37% | 3.91% | 379.69% | -137.21% | 204.24% | -230.95% | 5% | -14.89% | 19.49% | -9.92% | 5.65% | -3.88% | -7.86% | 12% | 14.68% | 17.2% | 8.14% |
| EPS (Basic) | - | -0.59 | 5.21 | 2.59 | 3.74 | 4.89 | 3.29 | 3.79 | 4.79 | 5.54 | 3.82 | 3.11 | 2.68 | 2.32 | 2.10 | 1.87 | 1.80 | -0.64 | 1.73 | -1.65 | 1.27 | 1.22 | 1.43 | 1.20 | 1.33 | 1.27 | 1.33 | 1.45 | 1.29 | 1.12 | 0.96 |
| Diluted Shares Outstanding | 31.1M | 31.4M | 32.3M | 32.6M | 32.8M | 33.8M | 34.2M | 35.1M | 35.6M | 35.6M | 35.2M | 35M | 34.8M | 34.98M | 35.5M | 36.24M | 37.39M | 37.45M | 37.97M | 38.38M | 39.49M | 41.13M | 41.54M | 46.68M | 41.19M | 40.16M | 42.02M | 44.36M | 45.76M | 46.15M | 46.34M |
| Basic Shares Outstanding | 31.1M | 31.4M | 32.1M | 32.5M | 32.7M | 33.6M | 34.2M | 35M | 35.3M | 35.2M | 34.9M | 34.7M | 34.5M | 34.69M | 35.3M | 36.02M | 37.23M | 37.45M | 37.79M | 38.38M | 39.18M | 40.69M | 41.06M | 46.1M | 40.42M | 39.21M | 40.91M | 42.83M | 44.51M | 45.11M | 45.13M |
| Dividend Payout Ratio | - | - | 7.9% | 9.63% | 5.32% | 4.14% | 6.05% | 5.28% | 4.2% | 3.59% | 5.25% | 6.49% | 7.47% | 8.65% | 5.95% | 5.33% | 5.56% | - | 5.79% | - | 7.83% | 7.64% | 7% | 2.89% | 3.77% | 3.94% | 3.78% | 3.38% | 3.85% | 4.57% | 5.34% |
Quick answers to the most common questions about buying MTX stock.
For fiscal year 2025, Minerals Technologies Inc. (MTX) reported total revenue of $2.07B. This represents a 272.8% increase compared to $556.0M in 1996.
Minerals Technologies Inc. (MTX) reported a net loss of $18.4M for the fiscal year ending 2025.
Minerals Technologies Inc. (MTX) reported an operating income of $287.1M, resulting in an operating profit margin of 13.9%. This margin reflects the operational efficiency of the business before interest and taxes.
Minerals Technologies Inc. (MTX) generated $506.6M in gross profit for the year, representing a gross profit margin of 24.4%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Impairment charges distorting earnings
Metrics are mathematically derived from official filings.
Revenue Growth Stalls Amid Mixed Signals
MTX's revenue growth has been erratic, with a 3.7% increase in 2026Q2 but a 2.3% decline in 2025Q2, indicating inconsistent demand. According to quarterly financials, the latest uptick may reflect pricing or mix shifts rather than volume strength.
The 10-quarter revenue trend shows a pattern of alternating contractions and modest expansions, with the most recent quarter (2026Q2) posting 3.7% growth after a 0.3% rise in 2025Q4. This volatility suggests end-market fragility, possibly tied to cyclical industrial demand. The lack of consistent acceleration implies that any growth is not yet durable, and investors should monitor whether the 2026Q2 uptick can be sustained.
Gross Margin Compression Signals Pricing Pressure
Gross margin has slipped from 26.6% in 2024Q2 to 24.4% in 2026Q2, a 220 basis point decline. As reported in financial statements, this erosion suggests input cost inflation or weaker pricing power relative to peers like Ecolab's 44.5%.
The downward drift in gross margin, despite revenue stability, indicates that MTX is unable to fully pass through cost increases. This is particularly concerning given that specialty chemical peers such as Balchem and Ecolab maintain significantly higher margins, implying MTX may be facing competitive pricing pressure or a less favorable product mix. The recent stabilization around 24% in 2026 could signal a floor, but the structural gap to peers warrants close attention.
Operating Leverage Reverses Sharply
Operating income swung from a $79.0M profit in 2025Q2 to a $215.4M loss in 2026Q2, a dramatic reversal. Based on reported figures, this collapse appears driven by a one-time impairment, not operational deterioration, as SG&A remained flat.
Excluding the impairment, operating leverage appears stable, with SG&A as a percentage of revenue hovering around 10-11% in recent quarters. However, the massive loss in 2026Q2 underscores the impact of non-operating charges on reported profitability. The underlying operating margin, around 12-15% in prior quarters, suggests that the company's cost structure is not inherently inefficient, but the impairment highlights potential balance sheet or goodwill concerns.
Earnings Quality Marred by Impairment Charges
Net income swung from a $45.4M profit in 2025Q2 to a $183.6M loss in 2026Q2, with EPS at -$5.91. According to SEC filings, this volatility is largely due to a one-time impairment, but it obscures underlying profitability.
The 2026Q2 loss appears to be an outlier, as prior quarters showed consistent profitability with net margins around 7-10%. The absence of stock-based compensation in the data suggests that reported earnings are not being diluted by SBC, but the impairment charge raises questions about asset valuations and potential future write-downs. Investors should adjust for such non-recurring items to assess normalized earnings power.
Cost Discipline Holds Despite Revenue Fluctuations
COGS as a percentage of revenue has remained relatively stable, ranging from 73.4% to 75.8% over the past year. As reported in financial statements, this stability suggests effective cost management, though gross margin compression indicates input costs are outpacing pricing.
SG&A expenses have been well-controlled, with only a modest increase from $50.1M in 2024Q3 to $57.5M in 2026Q2, despite revenue growth. R&D spending has been consistent at around $5.6-6.1M, indicating a steady investment in innovation. However, the rising COGS ratio implies that the company is absorbing cost increases, which could pressure margins if not addressed through pricing or productivity gains.
2026Q2 Impairment Marks a Critical Inflection
The $215.4M operating loss in 2026Q2 represents a stark inflection point, reversing years of steady profitability. Based on reported figures, this appears driven by a one-time impairment, but its magnitude signals potential strategic or asset quality issues.
Prior to 2026Q2, MTX consistently generated operating income between $54.8M and $79.2M, with net income positive. The sudden loss suggests a major write-down, possibly related to goodwill or long-lived assets. This inflection could indicate a shift in the company's portfolio or a deterioration in certain business segments. The lasting impact will depend on whether this is a one-time event or a precursor to further impairments, warranting close monitoring of future disclosures.
What Could Invalidate the Base Case
The 2026Q2 impairment may signal deeper asset quality issues, and the persistent gross margin gap versus peers suggests structural competitive weakness. As reported in financial statements, these factors could pressure future earnings beyond the one-time charge.
Short-sellers might argue that the impairment is not truly one-time, as the gross margin decline from 26.6% to 24.4% over the past year indicates ongoing pricing pressure that could lead to further write-downs. Additionally, the company's operating margin, even excluding the impairment, lags behind peers like Ecolab and Balchem, suggesting a lack of pricing power. If revenue growth remains erratic and margins continue to compress, the market may re-rate MTX lower, making the current valuation appear unjustified.